"High-tech patient care with a multidisciplinary approach to treatment of cancer is the hallmark of the Willis-Knighton Cancer Center. The center offers patients: Internationally-recognized radiation oncology program, with leading-edge proton beam therapy center. Spacious, comfortable infusion therapy program Experienced and compassionate physicians and support staff Board Certified medical physicists Physician offices on-site Laboratory services on-site Support groups and services for patients and caregivers Convenient location just off Interstate 20 Distinguished accreditations We treat prostate, lung, breast, colo-rectal, gynecologic (ovarian, cervical, vulvar, endometrial, etc.),hepatobilliary (liver, pancreas, etc.), head and neck."

During the past decade, Willis-Knighton Cancer Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Willis-Knighton Cancer Center" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "C. R. Bard" with 2 trials sponsored, "NRG Oncology" with 2 trials sponsored, "Agendia" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Willis-Knighton Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Willis-Knighton Cancer Center" are "Breast Cancer" (3 trials), "Multiple Myeloma" (2 trials), "Oral Mucositis" (2 trials), "Adult Giant Cell Glioblastoma" (1 trials) and "Adult Glioblastoma" (1 trials). Many other conditions were trialed in "Willis-Knighton Cancer Center" in a lesser frequency.

Most popular intervention types in "Willis-Knighton Cancer Center" are "Drug" (17 trials), "Other" (7 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Laboratory Biomarker Analysis" (2 trials), "Paclitaxel" (2 trials), "Quality-of-Life Assessment" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Willis-Knighton Cancer Center" are 18 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Willis-Knighton Cancer Center". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Willis-Knighton Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Willis-Knighton Cancer Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".